Cantitate/Preț
Produs

Trends in Leukemia Research

Editat de Rafael M. Romero
en Limba Engleză Hardback – 19 iun 2005
This new book brings together leading research from around the globe. Leukaemia is cancer that begins in blood cells. In people with leukaemia, the bone marrow produces abnormal white blood cells. The abnormal cells are leukaemia cells. At first, leukaemia cells function almost normally. In time, they may crowd out normal white blood cells, red blood cells, and platelets. The scope of the book includes the four common types of leukaemia: Chronic lymphocytic leukaemia (chronic lymphoblastic leukaemia, CLL) most often affecting people over age 55. Chronic myeloid leukaemia (chronic myelogenous leukaemia, CML) affects mainly adults. Acute lymphocytic leukaemia (acute lymphoblastic leukaemia, ALL) the most common type of leukaemia in young children. Acute myeloid leukaemia (acute myelogenous leukaemia, AML) which occurs in both adults and children. New advances in diagnosis, pathogenesis and therapy are presented.
Citește tot Restrânge

Preț: 95850 lei

Preț vechi: 131735 lei
-27% Nou

Puncte Express: 1438

Preț estimativ în valută:
18346 19121$ 15272£

Carte disponibilă

Livrare economică 14-28 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781594543111
ISBN-10: 1594543119
Pagini: 204
Ilustrații: b/w & colour illus
Dimensiuni: 180 x 263 x 19 mm
Greutate: 0.7 kg
Editura: Nova Science Publishers Inc

Cuprins

Preface; Genetic Susceptibility to Childhood Acute Lymphoblastic Leukaemia; Improved Outcome in Childhood Acute Lymphoblastic Leukaemia Treated Independently of Risk Factors; Children with Leukaemia: Innovative Approaches in Psychosocial Rehabilitation; The Specific N-Ras Mutation and other Genetic Changes in DMBA-Induced Rat Leukemia as a Target Effect of DMBA; Review with a Hypothesis; Chronic Myelogenous Leukaemia as a Model of Gene Activation in Oncology; Nucleoli in Blood Cells of Hematologic Malignancies (Structure, Cytochemistry of Nucleoli in Leukaemia, Lymphoma and Myeloma Cells); Chronic Lymphocytic Leukaemia: Time for a Risk-Adapted Approach; Index.